PBYI
Puma Biotechnology, Inc.
9.80$
+2.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -96.4% | +2,481.3% | -176.6% | – | +44.1% | +7.4% | |
| – | +23.8% | +48.1% | +144.6% | +162.7% | +9.4% | +24.2% | +12.7% | -13.0% | +17.1% | +0.0% | -5.1% | |
| – | +142.5% | +23.5% | -7.3% | -20.0% | -34.1% | -36.2% | -10.8% | -63.8% | -13.4% | -19.5% | -15.8% | |
| – | +141.8% | +23.7% | -7.6% | -19.8% | -23.6% | -43.6% | +5.9% | -52.7% | – | – | – | |
| – | -144.7% | – | -36.7% | -164.8% | – | -43.5% | -109.9% | – | – | – | – | |
| – | -8.6% | +516.8% | +592.4% | -98.8% | -49.8% | +6,451.0% | -100.0% | +699,900.0% | +80.6% | -99.6% | +26.8% | |
| – | +35.7% | – | -110.8% | +274.0% | – | +351.3% | -146.7% | – | -369.2% | +6.9% | +77.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +71.6% | -30.4% | -83.6% | -71.3% | -82.3% | -95.0% | – | – | – | – | – | |
| – | +0.0% | +0.0% | -3.1% | +108.2% | -167.9% | -97.8% | +0.0% | -100.0% | – | – | +33.3% | |
| – | +71.6% | -30.4% | -53.8% | +44.3% | -161.9% | – | -32,031.0% | – | -80.1% | -1,492.3% | +33.5% | |
| – | – | – | -169.2% | – | -247.9% | – | -191.4% | – | +125.3% | -294.9% | – | |
| – | – | – | – | – | – | -187.2% | – | -210.5% | – | +170.5% | +7.4% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.